EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional liver genomics identifies hepatokines promoting wasting in cancer cachexia

Doris Kaltenecker, Søren Fisker Schmidt, Peter Weber, Anne Loft, Pauline Morigny, Juliano Machado, Julia Geppert, Kerstin Beate Saul, Pia Benedikt, Claudia-Eveline Molocea, Rachel Scott, Kerstin Haase und 19 weitere

Cell · 2025-08 · 188 (17) · 4549-4566.e22

DOI: 10.1016/j.cell.2025.06.039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-08. Verfasst von Doris Kaltenecker und 30 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Diabetes and Cancer (IDC), Helmholtz Munich, German Research Center for Environmental Health, 85764 Neuherberg, Germany; Joint Heidelbe…. Hauptthemen laut MEDLINE: Cachexia, Liver, Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UCLH Biomedical Research Centre, National Institutes of Health National Cancer Institute, Horizon 2020 Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In cancer cachexia, the presence of a tumor triggers systemic metabolic disruption that leads to involuntary body weight loss and accelerated mortality in affected patients. Here, we conducted transcriptomic and epigenomic profiling of the liver in various weight-stable cancer and cancer cachexia models. An integrative multilevel analysis approach identified a distinct gene expression signature that included hepatocyte-secreted factors and the circadian clock component REV-ERBα as key modulator of hepatic transcriptional reprogramming in cancer cachexia. Notably, hepatocyte-specific genetic reconstitution of REV-ERBα in cachexia ameliorated peripheral tissue wasting. This improvement was associated with decreased levels of specific cachexia-controlled hepatocyte-secreted factors. These hepatokines promoted catabolism in multiple cell types and were elevated in cachectic cancer patients. Our findings reveal a mechanism by which the liver contributes to peripheral tissue wasting in cancer cachexia, offering perspectives for future therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaLiverNeoplasmsHumansAnimalsMiceHepatocytesMaleNuclear Receptor Subfamily 1, Group D, Member 1GenomicsFemaleTranscriptomeMice, Inbred C57BL

Stichwörter der Autor:innen

INTACTREV-ERBadipose tissue wastingcachexiacircadian clockhepatic reprogrammingliver-secreted factorsmuscle atrophy

Substanzen

Nuclear Receptor Subfamily 1, Group D, Member 1

Autor:innen und Institutionen

  • Institute for Diabetes and Cancer (IDC), Helmholtz Munich, German Research Center for Environmental Health, 85764 Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital,…
  • Heidelberg University, Medical Faculty Heidelberg, Institute of Experimental Cardiology, 69120 Heidelberg, Germany; Heidelberg University Hospital, Department of Internal Medicine VIII, 69120 Heidelberg, Germany; German…
  • Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, WC1E 6BT London, UK; Cancer Metastasis Laboratory, University College London Cancer Institute, WC1E 6DD London, UK.
  • Department of Surgery, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
  • Cancer Metabolism Research Group, LIM 26 HC, Medical School, University of São Paulo, 01246-904 São Paulo, Brazil.
  • Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, WC1E 6BT London, UK; Department of Oncology, University College London Hospitals, NW1 2PB London, UK; Cancer Evolution and…

Förderung

  • UCLH Biomedical Research Centre
  • National Institutes of Health National Cancer Institute
  • Horizon 2020 Framework Programme
  • University College London
  • University of Pennsylvania
  • Deutsches Zentrum für Infektionsforschung
  • Cancer Research UK
  • Bundesministerium für Forschung, Technologie und Raumfahrt

Zitieren

APA

Kaltenecker, D., Fisker Schmidt, S., Weber, P., Loft, A., Morigny, P., Machado, J., Geppert, J., Saul, K. B., Benedikt, P., Molocea, C. E., Scott, R., Haase, K., Martignoni, M. E., Alfaro, A. J., Chow, K. K., Simoes, E., Pinhata Otoch, J., Lima, J. D. C. C., Swanton, C., …, & Berriel Diaz, M. (2025). Functional liver genomics identifies hepatokines promoting wasting in cancer cachexia. Cell, 188(17), 4549-4566.e22. https://doi.org/10.1016/j.cell.2025.06.039

Vancouver

Kaltenecker D, Fisker Schmidt S, Weber P, Loft A, Morigny P, Machado J, et al. Functional liver genomics identifies hepatokines promoting wasting in cancer cachexia. Cell. 2025;188(17):4549-4566.e22. doi:10.1016/j.cell.2025.06.039

BibTeX
@article{Kaltenecker2025,
  author = {Kaltenecker, Doris and Fisker Schmidt, Søren and Weber, Peter and Loft, Anne and Morigny, Pauline and Machado, Juliano and Geppert, Julia and Saul, Kerstin Beate and Benedikt, Pia and Molocea, Claudia-Eveline and Scott, Rachel and Haase, Kerstin and Martignoni, Marc E and Alfaro, Ana Jimena and Chow, Kan Kau and Simoes, Estefania and Pinhata Otoch, José and Lima, Joanna D C C and Swanton, Charles and Spielmann, Nadine and Hrabé de Angelis, Martin and Elsner, Markus and Ertürk, Ali and Dyar, Kenneth A and Rohm, Maria and Prokopchuk, Olga and Jamal-Hanjani, Mariam and Seelaender, Marilia and Backs, Johannes and Herzig, Stephan and Berriel Diaz, Mauricio},
  title = {Functional liver genomics identifies hepatokines promoting wasting in cancer cachexia},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {17},
  pages = {4549--4566.e22},
  doi = {10.1016/j.cell.2025.06.039}
}
Kostenlos starten →